Catalent to buy supplement maker Bettera Holdings in $1B deal

  • Catalent (NYSE:CTLT) has agreed to acquire closely held vitamin and supplements maker Bettera Holdings for $1B in cash, in a deal expected to be announced tomorrow, WSJ reports.
  • The deal would expand Catalent's manufacturing capabilities for vitamins, minerals and supplements to make them in gummy form, according to the report.
  • Bettera's sales last year reportedly totaled $150M and are forecast to grow at least 20% annually in the short term.
  • Catalent's last comparable acquisition was a $1.2B deal for Paragon Bioservices in 2019.

    Over the current book year the total revenu from the company based in Somerset will be 4.48 billion USD (consensus estimates). This is rather significant more than 2021's revenue of 4 billion USD.

    Historical revenues and results Catalent Inc. plus estimates 2021

    financiële analyse

    The analysts expect for 2021 a net profit of 657 million USD. For this year most of the analysts expect a profit per share of 3.52 USD. The price-earnings-ratio equals 39.66.

    For this year analysts don't expect the company to pay a dividend. The average dividend yield of the biotech companies equals a relatively high 2.64 percent.

    Catalent Inc.'s market capitalization is based on the number of outstanding shares around 22.73 billion USD. 62

    At 18.08 the stock trades 0.06 percent higher at 139.6 USD.

    Price data Catalent Inc. 2007-2021

    stock price catalentinc.

    ValueSpectrum.com News Wire & Equity Research: +31 084-0032-842
    news@valuespectrum.com

    Copyright analist.nl B.V.
    All rights reserved. Any redistribution, duplication or archiving prohibited. analist.nl doesn't warrant the accuracy of any News Content provided and shall not be liable for any errors, inaccuracies or for any actions taken in reliance thereon.

    • Sector news
    Analysts anticipate for 2024 on revenue increase Astrazeneca, high dividend yield
    High dividend yield Sanofi-Aventis
    Sanofi-Aventis in top French dividend returns
    Novartis among highest Swiss dividend stocks
    Analysts expect over 2023 revenue increase UCB
    Pfizer CEO Bourla says company prepared if modified COVID vaccine required
    Analysts: this year best year ever for Carl Zeiss Meditec
    National news
    NXP reaps benefits from FRAMOS collaboration
    Tesla net onder de 500.000 cars per year
    Analysts expect over 2024 revenue decrease Caterpillar
    Analysts expect sales decline Biogen
    Analysts anticipate for 2024 on revenue increase Cognizant
    Analysts expect over 2024 growing sales Colgate-Palmolive
    Analysts expect over 2024 revenue expansion Patterson-UTI Energy, relatively high dividend
    Press news
    Test News
    Endeavour Announces Holding(s) in Company
    Military Shipbuilding & Submarine Market is Expected to Reach US$ 126.84 Billion by 2034, Growing at 4.6% CAGR | Fact.MR Report
    Ocular Prosthesis Market Trends, Challenges and Opportunities to 2030: A Projected $2.3 Billion Landscape
    Middlefield Canadian Income PCC: Net Asset Value(s)
    Growth Trends in the Industrial Stackers Market, 2024-2030 - Increased Adoption of Electric Stackers for Sustainable and Energy-Efficient Operations Expands Addressable Market
    HSBC Bank Plc - Form 8.5 (EPT/RI) - Learning Technologies Group plc
    Logoanalist
    Returns European stocks
    Crypto currencies information
    About us Network Partners
    Fpgroup.nlinfo@analist.nlRSS feedContactIntellectual Property Photos Analist.nlLinksISIN
  • Glossary
    		• MorningstarPrudena.comAAII.comNASDAQvwd GroupEuronextBATS Chi-xBats
    ©2024 ValueSpectrum. All Rights Reserved
    Developed and maintained by  Velainn logo